Medical Oncology and Hematology 2014: Multidisciplinary Approaches that Improve Coordination of Care
October 16-17, 2014
The University of Texas MD Anderson Cancer Center
R. Lee Clark Clinic – Floor 11, Hickey Auditorium
1515 Holcombe Blvd, Houston, Texas
- Conference Brochure
- Conference Agenda
- Committee and Speakers
- Registration Information
- Hotel and Transportation Information
- Houston Visitor Information
- Houston Entertainment
- Directions to MD Anderson
- Address the ongoing need for educating practicing physicians about new cancer therapies, current treatment guidelines, and resources available to assist them in their cancer
- Enhance understanding about the unique medical and psychosocial needs of cancer survivors and provide awareness for resources that can assist in navigating the various
phases of cancer survivorship.
- Focus on new advances within the last year along with other groundbreaking scientific discoveries.
- Raise awareness and knowledge in optimal use of new
- Incorporate prognostic factors and guidelines by tumor site into clinical practice, providing more accurate, personalized diagnoses and optimal treatment options for improved patient care in hematology and solid tumor oncology (knowledge, competence, performance, patient outcomes);
- Apply current screening guidelines and recommendations to detect cancer in primary care settings early enough for optimal referral, treatment, and outcomes (knowledge, competence, performance, patient outcomes);
- Be equipped with an awareness of the cancer care continuum and the place of primary care, as well as the resources available for assisting patients through phases of cancer survivorship (knowledge, competence, performance, patient outcomes);
- Provide patients with prevention guidance as well as accurate detection of possible breast cancer before metastasis and efficient referrals to specialists who provide up-todate
optimal treatment plans (knowledge, competence, performance, patient outcomes);
- Offer vaccinations and other proven prevention strategies, as well as emerging targeted therapies that address the issues of cytotoxicity, resistance, sensitivity, and adverse side effects in gynecologic malignancies (knowledge, competence).
This conference will be beneficial to medical oncologists, hematologists, primary care physicians, trainees, fellows, and healthcare professionals.
- Questions and Answers Sessions
- Case Studies
- Conference Post-Evaluation
A course evaluation form will provide participantsvwith the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Certificates and Attendance Verification Certificates
Certificates awarding AMA PRA Category 1 Credits™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.
Upon request, a record of attendance (certificate) will be provided on-site to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.